July 21, 2023 07:11 AM EDT

Codexis cuts 25% of staff, slashes drug programs while doubling down on RNAi tech

Amber Tong

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

view job offer post your job now

TRENDING NOW

Novo Nordisk CEO to step down, timeline for successor unknown

'Go ahead and do it': Top RFK Jr. deputy dares drugmakers that might pull manufacturing over new price pressure

Novo Nordisk’s global obesity leader is moving on; Flagship biotech gets CEO from Scholar Rock

The inside story of the six-month sprint to create the first custom CRISPR therapy for one infant’s rare disease

It's been three months without a biotech IPO

RFK Jr. adopts new chikungunya vaccine guidance; other recommendations remain under review